Resources

Classification of CKD

CKD is classified based on eGFR and albuminuria (ACR) categories.

Prognosis and Frequency of Testing

Early identification and management of CKD can reduce progression and cardiovascular risk. CKD prognosis for mortality, CVD and kidney function progression is determined by eGFR and albuminuria (ACR).

Framingham Calculator

Early prevention of CKD can reduce progression and cardiovascular risk. CKD prognosis for mortality, CVD and kidney function progression is determined by eGFR and albuminuria (ACR).

Start Calculator

Framingham Calculator

Gender

Male

Female

Age

Select 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+

*enter value

Diabetes

Yes

No

Does the patient have a first-degree relative who is
male <55 years old or female<65 years old with
cardiovascular disease?

Yes

No

Smoker

Yes

No

HDL-C
(mmol/L)

Select <0.9 0.9-1.19 1.2 - 1.29 1.3-1.6 >1.6

*enter value

Total
Cholesterol
(mmol/L)

Select <4.1 4.1-5.2 5.2-6.2 6.2-7.2 >7.2

*enter value

Systolic BP
(mmHg)

Select <120 120-129 130-139 140-149 150-159 160+

*enter value

 

Is blood pressure being treated with medications?

 

 

Yes

No

 

Calculate

Reset

10-year CVD Risk Score = — —%

Comprehensive Annual Care Plan (CACP)

For physicians practicing in Alberta, Canada the template integrates CKD guidelines and resources.

Kidney Failure Risk Equation

This equation predicts the 2 year and 5 year risk of treated kidney failure (dialysis or transplantation).

Management of Elevated Serum Potassium

Elevated serum potassium can develop due to a variety of factors including use of certain medications and high dietary potassium intake among patients with CKD. The approach to management of elevated serum potassium is dependent upon the cause and the degree of elevation in the potassium.

Management of elevated serum potassium (PDF)

Potassium Food Handout (PDF)

Drugs that may raise potassium (PDF)

My Kidneys My Health

My Kidneys My Health is an interactive self-management tool that provides guidance and supporting information to patients with CKD and their caregivers.

Conservative Kidney Management Pathway

Conservative Kidney Management (CKM) is a treatment option for patients with advanced kidney disease (eGFR < 15) who are unlikely to benefit from dialysis.

Clinical practice guidelines

The content contained on the CKD Clinical Pathway website is based on current research, the following existing evidence-based clinical guidelines, and clinical consensus.

KDIGO CKD (PDF)

KDIGO Lipids (PDF)

CDA Diabetes (PDF)

CHEP Hypertension (PDF)

CCS Antiplatelet

CCS Lipids